RightSign Neutralising Antibody Rapid Test

The RightSign rapid test for neutralising antibodies is used to check whether a COVID-19 vaccination has been successful and the patient has produced SARS-CoV-2 neutralising antibodies. In addition, the rapid test can also be used to check whether neutralising antibodies are detectable in the blood after a patient has survived a COVID-19 infection.

The qualitative rapid test can be performed with serum, plasma, venous whole blood and capillary blood from the fingertip. It provides reliable test results within only 10 minutes.

Please note: The control line is blue - if the test is successful, the colour changes to pink.

Product Details

• RightSign Neutralising Antibody Rapid Test
• Qualitative detection in whole blood, serum or plasma
• Test can also be performed with capillary blood from the fingertip
• Relative sensitivity: 100.0%
• Relative specificity: 100.0%
• Accuracy: 100.0%
• No cross-reactivity with other common antibodies, e.g. anti-influenza A virus, anti-influenza B virus or anti-RSV
• Storage temperature: 2 - 30°C (all materials must be brought to room temperature prior to testing)
• For use by healthcare professionals only
• Please note: this rapid test is excluded from the right of return
• 1 Pack with 25 rapid tests

Delivery Contents

• 25 test cassettes
• Buffer solution
• 25 pipettes or capillary tubes (may vary depending on batch)
• Package insert